Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The ...

The Kremlin has commented on Donald Trump's decision to boost weapons shipments heading to Ukraine. Elsewhere, the EU has failed to approve a new sanctions package on Russia. Follow the latest below.